Reshma Shringarpure
No ORCID on file
· 1 paper in corpus
observational
2013
OBJECTIVES: Adverse events (AEs) of ischemic colitis (IC) and complications of constipation (CoC) associated with alosetron are rare and have been adjudicated during the first 5.5 years of the risk management program (RMP); however, changes…